BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ren N, Ye QH, Qin LX, Zhang BH, Liu YK, Tang ZY. Circulating DNA level is negatively associated with the long-term survival of hepatocellular carcinoma patients. World J Gastroenterol 2006; 12(24): 3911-3914 [PMID: 16804981 DOI: 10.3748/wjg.v12.i24.3911]
URL: https://www.wjgnet.com/1948-5182/full/v12/i24/3911.htm
Number Citing Articles
1
Wim Laureyn, Tim Stakenborg, Paul Jacobs. Handbook of Biosensors and Biochips2007;  doi: 10.1002/9780470061565.hbb111
2
Qianwei Ye, Sunbin Ling, Shusen Zheng, Xiao Xu. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNAMolecular Cancer 2019; 18(1) doi: 10.1186/s12943-019-1043-x
3
Alberto Ocaña, Laura Díez-González, Dolores C. García-Olmo, Arnoud J. Templeton, Francisco Vera-Badillo, María José Escribano, Gemma Serrano-Heras, Verónica Corrales-Sánchez, Bostjan Seruga, Fernando Andrés-Pretel, Atanasio Pandiella, Eitan Amir. Circulating DNA and Survival in Solid TumorsCancer Epidemiology, Biomarkers & Prevention 2016; 25(2): 399 doi: 10.1158/1055-9965.EPI-15-0893
4
Yu-Jie Gao, Yu-Juan He, Zai-Lin Yang, Hui-Yuan Shao, Yan Zuo, Yao Bai, Hui Chen, Xian-Chun Chen, Feng-Xian Qin, Shi Tan, Jian Wang, Li Wang, Ling Zhang. Increased integrity of circulating cell-free DNA in plasma of patients with acute leukemiacclm 2010; 48(11): 1651 doi: 10.1515/CCLM.2010.311
5
恳 陈. Detection and Application of Circulating-Free Cell DNA in HepatopathyMedical Diagnosis 2013; 3(01): 10 doi: 10.12677/MD.2013.31003
6
Michele Dal Bo, Elena De Mattia, Lorena Baboci, Silvia Mezzalira, Erika Cecchin, Yehuda G. Assaraf, Giuseppe Toffoli. New insights into the pharmacological, immunological, and CAR-T-cell approaches in the treatment of hepatocellular carcinomaDrug Resistance Updates 2020; 51: 100702 doi: 10.1016/j.drup.2020.100702
7
Raphaël Saffroy, Patrick Pham, Maâmar Reffas, Mohamed Takka, Antoinette Lemoine, Brigitte Debuire. New perspectives and strategy research biomarkers for hepatocellular carcinomaClinical Chemical Laboratory Medicine 2007; 45(9) doi: 10.1515/CCLM.2007.262
8
Juan Wang, Liu Yang, Yanjun Diao, Jiayun Liu, Jinjie Li, Rui Li, Lianghong Zheng, Kang Zhang, Yueyun Ma, Xiaoke Hao. Circulating tumour DNA methylation in hepatocellular carcinoma diagnosis using digital droplet PCRJournal of International Medical Research 2021; 49(3): 030006052199296 doi: 10.1177/0300060521992962
9
Hon-Fan Lai, Shin-E Wang, Shih-Chin Chen, Bor-Shiuan Shyr, Yi-Ming Shyr, Bor-Uei Shyr. The emerging role of cell-free DNA as a molecular marker for duodenal adenocarcinomaJournal of the Chinese Medical Association 2024; 87(4): 422 doi: 10.1097/JCMA.0000000000001079
10
Farzaneh Banki, Wael N. Yacoub, Jeffrey A. Hagen, Rodney J. Mason, Shahin Ayazi, Steven R. DeMeester, John C. Lipham, Kathleen Danenberg, Peter Danenberg, Tom R. DeMeester. Plasma DNA Is More Reliable than Carcinoembryonic Antigen for Diagnosis of Recurrent Esophageal CancerJournal of the American College of Surgeons 2008; 207(1): 30 doi: 10.1016/j.jamcollsurg.2008.01.004
11
Franziska Hauth, Hannah J. Roberts, Theodore S. Hong, Dan G. Duda. Leveraging Blood-Based Diagnostics to Predict Tumor Biology and Extend the Application and Personalization of Radiotherapy in Liver CancersInternational Journal of Molecular Sciences 2022; 23(4): 1926 doi: 10.3390/ijms23041926
12
Dolores C. García-Olmo, Julia Samos, María G. Picazo, Ana I. Asensio, Inmaculada Toboso, Damián García-Olmo. Release of cell-free DNA into the bloodstream leads to high levels of non-tumor plasma DNA during tumor progression in ratsCancer Letters 2008; 272(1): 133 doi: 10.1016/j.canlet.2008.07.003
13
Jian Zhou, Ao Huang, Xin-Rong Yang. Liquid Biopsy and its Potential for Management of Hepatocellular CarcinomaJournal of Gastrointestinal Cancer 2016; 47(2): 157 doi: 10.1007/s12029-016-9801-0
14
Sravan Jeepalyam, Ankur Sheel, Aslam Ejaz, Eric Miller, Ashish Manne. Is Cell-Free DNA Testing in Hepatocellular Carcinoma Ready for Prime Time?International Journal of Molecular Sciences 2023; 24(18): 14231 doi: 10.3390/ijms241814231
15
Paola Ulivi, Rosella Silvestrini. Role of quantitative and qualitative characteristics of free circulating DNA in the management of patients with non-small cell lung cancerCellular Oncology 2013; 36(6): 439 doi: 10.1007/s13402-013-0155-3
16
Sherien F. El-Shazly, Manal A. Eid, Hesham A. El-Sourogy, Gehan F. Attia, Sherif A. Ezzat. Evaluation of Serum Dna Integrity as a Screening and Prognostic Tool in Patients with Hepatitis C Virus-Related Hepatocellular CarcinomaThe International Journal of Biological Markers 2010; 25(2): 79 doi: 10.1177/172460081002500204
17
Marianna Alunni-Fabbroni, Sabine Weber, Osman Öcal, Max Seidensticker, Julia Mayerle, Peter Malfertheiner, Jens Ricke. Circulating Cell-Free DNA Combined to Magnetic Resonance Imaging for Early Detection of HCC in Patients with Liver CirrhosisCancers 2021; 13(3): 521 doi: 10.3390/cancers13030521
18
Patrick Kirchweger, Helwig Valentin Wundsam, Holger Rumpold. Circulating tumor DNA for diagnosis, prognosis and treatment of gastrointestinal malignanciesWorld Journal of Clinical Oncology 2022; 13(6): 473-484 doi: 10.5306/wjco.v13.i6.473
19
Melanie B. Thomas, Deborah Jaffe, Michael M. Choti, Jacques Belghiti, Steven Curley, Yuman Fong, Gregory Gores, Robert Kerlan, Phillipe Merle, Bert O'Neil, Ronnie Poon, Lawrence Schwartz, Joel Tepper, Francis Yao, Daniel Haller, Margaret Mooney, Alan Venook. Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning MeetingJournal of Clinical Oncology 2010; 28(25): 3994 doi: 10.1200/JCO.2010.28.7805
20
Marika Piciocchi, Romilda Cardin, Alessandro Vitale, Veronica Vanin, Anna Giacomin, Caterina Pozzan, Gemma Maddalo, Umberto Cillo, Maria Guido, Fabio Farinati. Circulating free DNA in the progression of liver damage to hepatocellular carcinomaHepatology International 2013; 7(4): 1050 doi: 10.1007/s12072-013-9481-9
21
Hugo A. Barrera-Saldaña, Luis E. Fernández-Garza, Silvia A. Barrera-Barrera. Liquid biopsy in chronic liver diseaseAnnals of Hepatology 2021; 20: 100197 doi: 10.1016/j.aohep.2020.03.008
22
S. Garg, A. Kumar, R. Gupta. Stance of MRD in Non-Hodgkin’s Lymphoma and its upsurge in the novel era of cell-free DNAClinical and Translational Oncology 2021; 23(11): 2206 doi: 10.1007/s12094-021-02635-4
23
Kabir Mody, Sean P. Cleary. A Review of Circulating Tumor DNA in Hepatobiliary MalignanciesFrontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00212
24
Chang-Qing Yin, Chun-Hui Yuan, Zhen Qu, Qing Guan, Hao Chen, Fu-Bing Wang. Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived BiomarkersDisease Markers 2016; 2016: 1 doi: 10.1155/2016/1427849
25
Klaus Jung, Michael Fleischhacker, Anja Rabien. Cell-free DNA in the blood as a solid tumor biomarker—A critical appraisal of the literatureClinica Chimica Acta 2010; 411(21-22): 1611 doi: 10.1016/j.cca.2010.07.032
26
Sangjoon Park, Eun Jung Lee, Chai Hong Rim, Jinsil Seong. Plasma Cell-Free DNA as a Predictive Marker after Radiotherapy for Hepatocellular CarcinomaYonsei Medical Journal 2018; 59(4): 470 doi: 10.3349/ymj.2018.59.4.470
27
Jessica A. Howell, Shahid A. Khan, Susanne Knapp, Mark R. Thursz, Rohini Sharma. The clinical role of circulating free tumor DNA in gastrointestinal malignancyTranslational Research 2017; 183: 137 doi: 10.1016/j.trsl.2016.12.006
28
Yan-yan Yan, Qiao-ru Guo, Feng-hua Wang, Rameshwar Adhikari, Zhuang-yan Zhu, Hai-yan Zhang, Wen-min Zhou, Hua Yu, Jing-quan Li, Jian-ye Zhang. Cell-Free DNA: Hope and Potential Application in CancerFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.639233
29
Dipesh Kumar Yadav, Xueli Bai, Rajesh Kumar Yadav, Alina Singh, Guogang Li, Tao Ma, Wei Chen, Tingbo Liang. Liquid biopsy in pancreatic cancer: the beginning of a new eraOncotarget 2018; 9(42): 26900 doi: 10.18632/oncotarget.24809
30
Haiwei Li, Songqi Zhang, Ruochen Zhu, Zheng Zhou, Lu Xia, Hao Lin, Shuo Chen. Early assessment of chemotherapeutic response in hepatocellular carcinoma based on serum surface-enhanced Raman spectroscopySpectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2022; 278: 121314 doi: 10.1016/j.saa.2022.121314
31
Roberto A. Perego, Matteo Corizzato, Paola Brambilla, Stefano Ferrero, Cristina Bianchi, Ester Fasoli, Stefano Signorini, Barbara Torsello, Lara Invernizzi, Silvia Bombelli, Valentina Angeloni, Marina Pitto, Cristina Battaglia, Vanessa Proserpio, Fulvio Magni, Giacomo Galasso, Paolo Mocarelli. Concentration and microsatellite status of plasma DNA for monitoring patients with renal carcinomaEuropean Journal of Cancer 2008; 44(7): 1039 doi: 10.1016/j.ejca.2008.03.008
32
Jessica A Howell, Rohini Sharma. The clinical role of ‘liquid biopsy’ in hepatocellular carcinomaHepatic Oncology 2016; 3(1): 45 doi: 10.2217/hep.15.38
33
Claire Faltermeier, Ronald Busuttil, Ali Zarrinpar. A Surgical Perspective on Targeted Therapy of Hepatocellular CarcinomaDiseases 2015; 3(4): 221 doi: 10.3390/diseases3040221
34
Zhaohui Huang, Dong Hua, Yu Hu, Zhihong Cheng, Xike Zhou, Qigen Xie, Qiongyao Wang, Feng Wang, Xiang Du, Yanjun Zeng. Quantitation of Plasma Circulating DNA Using Quantitative PCR for the Detection of Hepatocellular CarcinomaPathology & Oncology Research 2012; 18(2): 271 doi: 10.1007/s12253-011-9438-z
35
Wendy V Jaraba Álvarez, Isaura P. Torres Gómez, Rubén D. Manrique Hernández, Juan E Gallo Bonilla. Estado actual de las aplicaciones del ADN libre de célula circulanteMedicina y Laboratorio 2017; 23(11-12): 551 doi: 10.36384/01232576.6
36
Chih-Lin Lin, Jia-Horng Kao. Hepatitis B Virus and Liver Disease2021; : 231 doi: 10.1007/978-981-16-3615-8_10
37
Onyinye Ugonabo, Utibe-Abasi Sunday Udoh, Pradeep Kumar Rajan, Heather Reeves, Christina Arcand, Yuto Nakafuku, Tejas Joshi, Rob Finley, Sandrine V. Pierre, Juan Ramon Sanabria. The Current Status of the Liver Liquid Biopsy in MASH Related HCC: Overview and Future DirectionsBiomolecules 2023; 13(9): 1369 doi: 10.3390/biom13091369
38
Nikolaus Kohles, Dorothea Nagel, Dietrich Jüngst, Jürgen Durner, Petra Stieber, Stefan Holdenrieder. Prognostic relevance of oncological serum biomarkers in liver cancer patients undergoing transarterial chemoembolization therapyTumor Biology 2012; 33(1): 33 doi: 10.1007/s13277-011-0237-7
39
Yahya Elshimali, Husseina Khaddour, Marianna Sarkissyan, Yanyuan Wu, Jaydutt Vadgama. The Clinical Utilization of Circulating Cell Free DNA (CCFDNA) in Blood of Cancer PatientsInternational Journal of Molecular Sciences 2013; 14(9): 18925 doi: 10.3390/ijms140918925
40
Klara Cervena, Pavel Vodicka, Veronika Vymetalkova. Diagnostic and prognostic impact of cell-free DNA in human cancers: Systematic reviewMutation Research/Reviews in Mutation Research 2019; 781: 100 doi: 10.1016/j.mrrev.2019.05.002
41
Dolores C García-Olmo, María G Picazo, Inmaculada Toboso, Ana I Asensio, Damián García-Olmo. Quantitation of cell-free DNA and RNA in plasma during tumor progression in ratsMolecular Cancer 2013; 12(1) doi: 10.1186/1476-4598-12-8
42
Silvia Mezzalira, Elena De Mattia, Michela Guardascione, Chiara Dalle Fratte, Erika Cecchin, Giuseppe Toffoli. Circulating-Free DNA Analysis in Hepatocellular Carcinoma: A Promising Strategy to Improve Patients’ Management and Therapy OutcomesInternational Journal of Molecular Sciences 2019; 20(21): 5498 doi: 10.3390/ijms20215498
43
Pengjun Zhang, Xinyu Wen, Feng Gu, Xinxin Deng, Juan Li, Jin Dong, Jiao Jiao, Yaping Tian. Methylation profiling of serum DNA from hepatocellular carcinoma patients using an Infinium Human Methylation 450 BeadChipHepatology International 2013; 7(3): 893 doi: 10.1007/s12072-013-9437-0